MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, J. A.
Right arrow Articles by Amara, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, J. A.
Right arrow Articles by Amara, S. G.

Stable expression of a neuronal gamma-aminobutyric acid transporter, GAT-3, in mammalian cells demonstrates unique pharmacological properties and ion dependence

JA Clark and SG Amara

Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.

The transport proteins that mediate gamma-aminobutyric acid (GABA) reuptake have been major targets for the development of agents to treat neurological diseases such as epilepsy, where augmentation of GABAergic function is indicated. The recent isolation of cDNAs for four distinct brain GABA carriers has provided an avenue for creating more specific and selective antagonists of GABA transport. An LLC-PK1 cell line stably expressing GABA transporter type 3 (GAT-3), a beta-alanine- sensitive neuronal GABA transporter, has been generated and used to examine the kinetics, ion dependence, and pharmacological properties of the transporter. In this cell line, the GAT-3 carrier transports GABA with an apparent Km of 4 microM and a Vmax of 1.25 x 10(-16) mol/cell/min. beta-Alanine is a relatively potent inhibitor of GAT-3 GABA transport, with a K(i) value of 34 microM. beta-Alanine also serves as a substrate for the carrier (Km = 29 microM, Vmax = 1.82 x 10(-16) mol/cell/min) and appears to interact with the transporter at the same or a similar site as GABA. Other experimental GABA transport antagonists developed as anticonvulsant agents, including tiagabine, Cl- 966, SKF-100330-A, SKF-89976-A, and NO-711, are weak inhibitors of GAT- 3 GABA transport, suggesting that their therapeutic effects may be more related to their ability to block GABA transporters other than GAT-3. GAT-3 exhibits a sigmoidal dependence on Na+ concentration, with a Hill coefficient of 1.65, suggesting that more than one Na+ ion is involved in the transport mechanism. In contrast, the transport activity shows a hyperbolic Cl- dependence, with a Hill coefficient of 1.05. The Km for Cl- is 78 mM, a value severalfold higher than has been noted for another cloned GABA carrier, GABA transporter type 1. Interestingly, for GAT-3 a reduction of the Cl- concentration results in a small but consistent increase in the apparent Km for GABA, suggesting that the interaction of chloride with the transporter may be an important initial event in the mechanism of transport. These results underscore the unique properties of GAT-3 and distinguish this transporter as a new target for the development of GABA-mimetic agents.

Volume 46, Issue 3, pp. 550-557, 09/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. D. Whitlow, A. Sacher, D. D. F. Loo, N. Nelson, and S. Eskandari
The Anticonvulsant Valproate Increases the Turnover Rate of gamma -Aminobutyric Acid Transporters
J. Biol. Chem., May 9, 2003; 278(20): 17716 - 17726.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
G. A. Kinney and W. J. Spain
Synaptically Evoked GABA Transporter Currents in Neocortical Glia
J Neurophysiol, December 1, 2002; 88(6): 2899 - 2908.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. Masson, C. Sagne, M. Hamon, and S. E. Mestikawy
Neurotransmitter Transporters in the Central Nervous System
Pharmacol. Rev., September 1, 1999; 51(3): 439 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Galli, L. D. Jayanthi, I. S. Ramsey, J. W. Miller, R. T. Fremeau Jr, and L. J. DeFelice
L-Proline and L-Pipecolate Induce Enkephalin-Sensitive Currents in Human Embryonic Kidney 293 Cells Transfected with the High-Affinity Mammalian Brain L-Proline Transporter
J. Neurosci., August 1, 1999; 19(15): 6290 - 6297.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. PALACIN, R. ESTEVEZ, J. BERTRAN, and A. ZORZANO
Molecular Biology of Mammalian Plasma Membrane Amino Acid Transporters
Physiol Rev, October 1, 1998; 78(4): 969 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. L. Gaspary, W. Wang, and G. B. Richerson
Carrier-Mediated GABA Release Activates GABA Receptors on Hippocampal Neurons
J Neurophysiol, July 1, 1998; 80(1): 270 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Zhang, M. E. Schaner, and K. M. Giacomini
Functional Characterization of an Organic Cation Transporter (hOCT1) in a Transiently Transfected Human Cell Line (HeLa)
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 354 - 361.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Minelli, S. DeBiasi, N. C. Brecha, L. Vitellaro Zuccarello, and F. Conti
GAT-3, a High-Affinity GABA Plasma Membrane Transporter, Is Localized to Astrocytic Processes, and It Is Not Confined to the Vicinity of GABAergic Synapses in the Cerebral Cortex
J. Neurosci., October 1, 1996; 16(19): 6255 - 6264.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics